glp-1 kidney side effects Peptide/GLP-1 Complications: 11 Hidden Risks and You Must Know Glucagon-like peptide-1 receptor agonists in

Established in 2011 by the Fralin Biomedical Research Institute, the International Quit & Recovery Registry helps to bring together a global community of over 10,000 individuals in recovery

GLP-1 receptor agonist injection in late pregnancy significantly reduced fetal body weight, even after restoration of maternal blood glucose concentration

adults worried about being able to afford health care for them and their family -- outranking other expenses like gas and groceries

Obesity changes your muscle 'engine type': Excess weight shifts muscle fiber composition, reducing efficient, fat-burning Type I fibers and increasing less efficient, fatigue-prone Type IIx fibers, worsening metabolic flexibility

India GLP-1 Receptor Agonists Obesity Drugs Market Insight The India GLP-1 receptor agonists obesity drugs accounted for the largest revenue share in Asia Pacific in 2024, driven by a growing obesity burden, increasing healthcare awareness, and the rapid expansion of urban healthcare infrastructure